TB diagnostics in India: Creating an ecosystem for innovation

Expert Review of Molecular Diagnostics

Volumn 12, Issue 1, 2012, Pages 21-24

  Engel, Nora ^a   Kenneth, John ^b   Pai, Madhukar ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

diagnostics; India; innovations; tuberculosis

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC TEST; EPIDEMIC; FUNDING; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE INDUSTRY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; INDIA; INTERPERSONAL COMMUNICATION; INVESTMENT; POINT OF CARE TESTING; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; HEALTH PROMOTION; HUMANS; INDIA; PUBLIC HEALTH; TUBERCULOSIS;

EID: 82955189219     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.80     Document Type: Conference Paper

References (16)

1. World Health Oganization. Global Tuberculosis Control. World Health Organisation, Geneva, Switzerland (2010).
2. Wallis RS, Pai M, Menzies D et al. Biomarkers and diagnostics for tuberculosis: Progress, needs, and translationinto practice. Lancet 375(9729), 1920-1937 (2010).
3. Batz HG, Cooke GS, Reid SD. Towards Lab-Free Tuberculosis Diagnosis. Treatment ActionGroup; Stop TB Partnership; Imperial College London; Medecins Sans Frontiers (2011).
4. ZorluG. Indiatakes the lead ontuberculosis innovation. Nat. News doi:10.1038/news.2011.489 (2011) (Epub ahead ofprint).
5. Economist Intelligence Unit. Healthcare in Asia. The Innovation Imperative. A white paper by the Economist Intelligence Unit (2011).
6. Small PM, Pai M. Tuberculosis diagnosis-time for agame change. N. Engl. J. Med. 363(11), 1070-1071 (2011).
7. Chaturvedi K, Chataway J, Wield D. Policy, markets and knowledge: Strategicsynergies inIndianpharmaceutical firms. Technol. Anal. Strategic Manag. 19(5), 565-588 (2007).
8. Kale D, Little S. Fromimitationto innovation: The evolutionofR&D capabilities and learningprocesses inthe Indianpharmaceutical industry. Technol. Anal. Strategic Manag. 19(5), 589-609 (2007).
9. NarayananPR, GargR, SanthaT, KumaranP. Shiftingthe focus oftuberculosis research inIndia. Tuberculosis 83(1-3), 135-142 (2003). (Pubitemid 36683563)
10. Central TB Division. TB India 2011. RNTCP Annual Status Report. Central TB DivisionDirectorate General ofHealth Services, Ministry ofHealth and Family Welfare, India(2011).
11. Perkins MD, Roscigno G, ZumlaA. Progress towards improved tuberculosis diagnostics for developingcountries. Lancet 367(9514), 942-943 (2006).
12. Specter M. A deadly misdiagnosis: Is it possible to save the millions ofpeople who die fromTB? New Yorker, 15 November (2010).
13. Uplekar M, PathaniaV, Raviglione MC. Private practitioners and publichealth: Weak links intuberculosis control. Lancet 358, 912-916 (2001). (Pubitemid 32900580)
14. World Health Oganization. Policy Statement: Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis. World Health Organization, Geneva, Switzerland, WHO/HTM/TB/2011.5 (2011).
15. Pai M. ImprovingTB diagnosis: Difference betweenknowingthe path and walkingthe path. Exp. Rev. Mol. Diag. 11(3), 241-244 (2011).
16. Pai M. Tuberculosis control inIndia: Time to get dangerously ambitious? Nat. Med. J. Ind. 24(2), 65-68 (2011).